Evidence map›Paper›PMID 29775575›Full record

ArticleMolecular cell2018

At Long Last, a C-Terminal Bookend for the Ubiquitin Code.

Andrew Chatr-Aryamontri, Almer van der Sloot, Mike Tyers

Abstract readComment
PubMed Publisher
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  2. Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.Frontiers in cell and developmental biology · 2022
    Review
  3. Article
  4. Review
  5. Molecular basis for ubiquitin ligase CRL2Nature chemical biology · 2021
    Article
  6. Article
  7. Degradation of proteins with N-terminal glycine.Nature structural & molecular biology · 2019
    Article
  8. N-degron and C-degron pathways of protein degradation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Andrew Chatr-AryamontriInstitute for Research in Immunology and Cancer, University of Montreal, Montreal, QC H3C 3J7, Canada.
Almer van der SlootInstitute for Research in Immunology and Cancer, University of Montreal, Montreal, QC H3C 3J7, Canada.
Mike TyersInstitute for Research in Immunology and Cancer, University of Montreal, Montreal, QC H3C 3J7, Canada. Electronic address: md.tyers@umontreal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ubiquitin-proteasome system controls the stability of myriad protein substrates via short sequence motifs called degrons. Studies by Koren et al. (2018) and Lin et al. (2018) have uncovered a broad new class of degrons located at the extreme C terminus of substrates.

Indexed as

Proteasome Endopeptidase ComplexUbiquitinProteinsUbiquitin-Protein LigasesProteasome Endopeptidase ComplexProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.